
Salia Farrokh describes how neurocritical care pharmacists have moved from answering questions to leading research, policy, and teaching, and why health systems must fund dedicated ICU pharmacists and protected time to sustain that growth.
Independent pharmacies are getting closer to ending DIR fees for good, thanks to the work of organizations, such as the NCPA.
Today's episode features Jack Mozloom and guests Ronna Hauser and Karry La Violette from NCPA who discuss advocacy and regulatory issues with DIR.





